Protein Microarray Market Report 2026

The protein microarray market size has grown strongly in recent years. It will grow from $4.3 billion in 2025 to $4.71 billion in 2026 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to growth in proteomics research initiatives, increasing use of microarrays in disease research, expansion of academic and clinical research centers, advancements in surface chemistry technologies, availability of high-density microarray platforms.

The protein microarray market size is expected to see strong growth in the next few years. It will grow to $6.69 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to increasing demand for personalized diagnostics, rising integration with AI-based protein analytics, expansion of translational research activities, growing use in drug target validation, increasing funding for precision medicine research. Major trends in the forecast period include increasing adoption of high-throughput protein microarrays, rising use in biomarker discovery programs, growing integration with automated sample processing, expansion of multiplex protein profiling applications, enhanced focus on data-rich proteomic analysis.

The growing adoption of genomics is anticipated to drive the expansion of the protein microarray market in the coming years. Genomics involves examining an organism's complete set of genetic material, encompassing its structure, function, and evolutionary variations. The surge in genomics adoption is supported by technological advancements, lower sequencing costs, and the potential for personalized medical treatments. Genomics benefits protein microarrays by offering detailed genetic information that aids in identifying and analyzing proteins, their interactions, and functions, enabling more precise and high-throughput protein profiling. For example, in December 2023, the World Health Organization reported that a Switzerland-based public health agency indicated 163 out of 194 surveyed countries, or approximately 84%, now possess national capacity for pathogen genomic sequencing. Consequently, the rising adoption of genomics is fueling growth in the protein microarray market.

Major companies operating in the protein microarray market are focusing on developing innovative platforms using advanced technologies, such as KREX technology, to facilitate high-throughput analysis of protein interactions, biomarker discovery, and disease diagnostics. KREX technology ensures that only correctly folded, full-length proteins are immobilized on the protein microarray surface, while misfolded proteins are removed. For example, in October 2023, Sengenics Corporation LLC, a US-based biotechnology firm, launched i-ome discovery. This comprehensive protein microarray platform improves disease diagnosis and therapeutic interventions by analyzing over 1,800 autoantigens. The combination of patented KREX technology and an advanced AI-based pipeline provides sensitive and precise autoantibody detection, representing a notable advancement in the protein microarray market.

In March 2023, Spectrum Solutions, a US-based material technology company, acquired Alimetrix and Microarrays Inc. for an undisclosed sum. This acquisition is intended to enhance Spectrum's portfolio by integrating custom qualitative and quantitative assay development, along with advanced array-based products used in biological research. Alimetrix, a US-based company, specializes in advanced diagnostics, particularly for infectious diseases. Microarrays Inc., also based in the US, focuses on providing protein microarrays.

Major companies operating in the protein microarray market are PerkinElmer Inc., Merck Group, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Bio-Rad Laboratories Inc., GenScript Biotech Corporation, Quanterix Corporation, Standard BioTools Inc., RayBiotech Life Inc., Sengenics Corporation LLC, PepperPrint GmbH, Quansys Biosciences Inc., Sciomics GmbH, Arrayit Corporation, LC Sciences, Full Moon BioSystems Inc., Meso Scale Diagnostics LLC, CDI Laboratories Inc., Grace Bio-Labs Inc., Zyomyx Inc.

North America was the largest region in the protein microarray market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the protein microarray market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the protein microarray market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the protein microarray market by increasing costs of imported microarray scanners, robotic arrayers, surface-coated slides, detection reagents, and analytical software components. Research institutions and diagnostic developers in North America and Europe are most affected due to reliance on imported high-end systems, while Asia-Pacific faces cost pressures in manufacturing and exporting microarray platforms. These tariffs are increasing project costs and slowing equipment upgrades. At the same time, they are encouraging regional manufacturing, local reagent development, and innovation in modular and cost-efficient protein microarray systems.

The protein microarray market research report is one of a series of new reports that provides protein microarray market statistics, including protein microarray industry global market size, regional shares, competitors with a protein microarray market share, detailed protein microarray market segments, market trends and opportunities, and any further data you may need to thrive in the protein microarray industry. This protein microarray market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Protein microarray is a high-throughput technology that involves attaching a large variety of proteins onto a solid surface. This approach enables comprehensive analysis of protein profiles, identification of biomarkers, and insights into disease mechanisms by measuring and quantifying interactions between proteins or between proteins and other biomolecules.

The main categories in the protein microarray market include lab-on-chips (microfluidics), protein chips, arrayers, integrated systems, and microarray systems. Lab-on-chips (microfluidics) are miniaturized devices that combine multiple laboratory functions on a single chip, allowing the handling and analysis of very small fluid volumes. The technologies encompass functional protein microarrays, analytical microarrays, and reverse phase protein microarrays, with applications in proteomics, diagnostics, antibody characterization, and protein functional studies. The primary end users include hospitals and clinics, research centers, academic institutions, and diagnostic facilities.

The protein microarray market consists of revenues earned by entities by providing services such as protein detection, quantification, and functional analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The protein microarray market includes sales of equipment, scanners, and slide washers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.